drug

ebronucimab

updated 3mo ago

by Akeso Inc

community read0 votes

🐶 often sniffed alongside

top 3

all catalysts(1)

phase 1 completion · 1

Apr 30, 2026

phase 1 completion

3mo ago

Akeso Inc — ebronucimab (Phase I Trial Completion)

ebronucimab

→

Trials studying ebronucimab

phase1A Study Evaluating the Single Subcutaneous Injection of Ebronucimab in Healthy Male Chinese Subjectsnot yet recruitingn=204
phase1A Study Evaluating the Single Subcutaneous Injection of Ebronucimab in Chinese Healthy Male Subjectsnot yet recruitingn=180

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 26m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

ebronucimab

updated 3mo ago

by Akeso Inc

community read0 votes

🐶 often sniffed alongside

top 3

all catalysts(1)

phase 1 completion · 1

Apr 30, 2026

phase 1 completion

3mo ago

Akeso Inc — ebronucimab (Phase I Trial Completion)

ebronucimab

→

Trials studying ebronucimab

phase1A Study Evaluating the Single Subcutaneous Injection of Ebronucimab in Healthy Male Chinese Subjectsnot yet recruitingn=204
phase1A Study Evaluating the Single Subcutaneous Injection of Ebronucimab in Chinese Healthy Male Subjectsnot yet recruitingn=180

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 26m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

ebronucimab

🐶 often sniffed alongside

all catalysts(1)

Trials studying ebronucimab

News(0)

Report a data issue

comments(0)

ebronucimab

🐶 often sniffed alongside

all catalysts(1)

Trials studying ebronucimab

News(0)

Report a data issue

comments(0)